AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2022

Mar 10, 2022

30198_dirs_2022-03-10_05a22f9d-7135-4716-8580-d56a5dfbab5e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2022-03-04

Reporting Person: Dolan Matthew Vincent (*)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7546	Direct

Footnotes

F1: Included in this number are 7,501 unvested restricted stock units, 1,034 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023 and 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024.